SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

High-resolution quantitative proteomics applied to the study of the specific protein signature in the sputum and saliva of active tuberculosis patients and their infected and uninfected contacts.

Mateos, J; Estévez, O; González-Fernández, Á; Anibarro, L; Pallarés, Á; Reljic, R; Gallardo, JM; Medina, I; Carrera, M (2019) High-resolution quantitative proteomics applied to the study of the specific protein signature in the sputum and saliva of active tuberculosis patients and their infected and uninfected contacts. J Proteomics, 195. pp. 41-52. ISSN 1876-7737 https://doi.org/10.1016/j.jprot.2019.01.010
SGUL Authors: Reljic, Rajko

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (4MB) | Preview
[img]
Preview
PDF (Supplementary figure 1) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (32kB) | Preview
[img] Microsoft Excel (Supplementary info 1) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (966kB)
[img] Microsoft Excel (Supplementary info 2) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (25kB)
[img] Microsoft Excel (Supplementary info 3) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (23kB)

Abstract

Our goal was to establish panels of protein biomarkers that are characteristic of patients with microbiologically confirmed pulmonary tuberculosis (TB) and their contacts, including latent TB-infected (LTBI) and uninfected patients. Since the first pathogen-host contact occurs in the oral and nasal passages the saliva and sputum were chosen as the biological fluids to be studied. Quantitative shotgun proteomics was performed using a LTQ-Orbitrap-Elite platform. For active TB patients, both fluids exhibited a specific accumulation of proteins that were related to complement activation, inflammation and modulation of immune response. In the saliva of TB patients, a decrease of in proteins related to glucose and lipid metabolism was detected. In contrast, the sputum of uninfected contacts presented a specific proteomic signature that was composed of proteins involved in the perception of bitter taste, defense against pathogens and innate immune response, suggesting that those are key events during the initial entry of the pathogen in the host. SIGNIFICANCE: This is the first study to compare the saliva and sputum from active TB patients and their contacts. Our findings strongly suggest that TB patients show not only an activation of processes that are related to complement activation and modulation of inflammation but also an imbalance in carbohydrate and lipid metabolism. In addition, those individuals who do not get infected after direct exposure to the pathogen display a typical proteomic signature in the sputum, which is a reflection of the secretion from the nasal and oral mucosa, the first immunological barriers that M. tuberculosis encounters in the host. Thus, this result indicates the importance of the processes related to the innate immune response in fighting the initial events of the infection.

Item Type: Article
Additional Information: © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: Acute-phase response, Biomarker discovery, Innate immune response, Shotgun proteomics, Tuberculosis, Acute-phase response, Biomarker discovery, Innate immune response, Shotgun proteomics, Tuberculosis, 0601 Biochemistry And Cell Biology, Analytical Chemistry, Biochemistry & Molecular Biology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: J Proteomics
ISSN: 1876-7737
Language: eng
Dates:
DateEvent
20 March 2019Published
18 January 2019Published Online
13 January 2019Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
643558Horizon 2020UNSPECIFIED
PubMed ID: 30660769
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/110688
Publisher's version: https://doi.org/10.1016/j.jprot.2019.01.010

Actions (login required)

Edit Item Edit Item